Clinical trial
The Regulatory Effect of Probiotics-Polygonatum Sibiricum on Liver Health and Metabolic Disorders in Middle-Aged and Elderly People: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study
NCT06873412 is registered in ClinicalTrials.gov with Wecare Probiotics Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Regulatory Effect of Probiotics-Polygonatum Sibiricum on Liver Health and Metabolic Disorders in Middle-Aged and Elderly People: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study
- Lead sponsor
- Wecare Probiotics Co., Ltd.
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- March 10, 2025
- Completion date
- December 1, 2026
- Enrollment
- 84 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.